Reviewing Lumexa Imaging (LMRI) and The Competition

Lumexa Imaging (NASDAQ:LMRI – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it compare to its peers? We will compare Lumexa Imaging to related businesses based on the strength of its institutional ownership, valuation, profitability, earnings, analyst recommendations, dividends and risk.

Institutional and Insider Ownership

56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 0.7% of Lumexa Imaging shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and price targets for Lumexa Imaging and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lumexa Imaging 1 0 4 2 3.00
Lumexa Imaging Competitors 1890 7763 13430 841 2.55

Lumexa Imaging currently has a consensus price target of $18.17, suggesting a potential upside of 27.57%. As a group, “Healthcare Providers & Services” companies have a potential upside of 21.92%. Given Lumexa Imaging’s stronger consensus rating and higher possible upside, research analysts plainly believe Lumexa Imaging is more favorable than its peers.

Valuation & Earnings

This table compares Lumexa Imaging and its peers gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Lumexa Imaging $1.06 billion -$47.10 million -26.37
Lumexa Imaging Competitors $21.36 billion $301.67 million -3.54

Lumexa Imaging’s peers have higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Lumexa Imaging and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Lumexa Imaging -1.96% -2.89% -0.98%
Lumexa Imaging Competitors -1.05% -139.10% -2.48%

About Lumexa Imaging

(Get Free Report)

Lumexa Imaging operates outpatient diagnostic imaging centers that provide radiology services to patients, referring physicians and healthcare providers. Its services include imaging used to help diagnose and monitor a range of medical conditions. The company offers diagnostic procedures such as MRI, CT, PET/CT, mammography, ultrasound and X-ray through its imaging centers and affiliated radiology practices. Lumexa serves communities across the United States, providing an outpatient option for medical imaging outside of a hospital setting.

Receive News & Ratings for Lumexa Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumexa Imaging and related companies with MarketBeat.com's FREE daily email newsletter.